33 completed, 33 recruiting, 21 active not recruiting, 20 terminated. 51 Not applicable, 29 Phase 2, 11 Phase 1, 7 Phase 3, 3 Early Phase 1.
Follow Anatomic Stage I Breast Cancer AJCC v8: new trials by email Literature Review of Anatomic Stage I Breast Cancer AJCC v8 trials Research Report on Anatomic Stage I Breast Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Navigation Program to Improve Survivorship Support Service Participation Among Non-metastatic Breast Cancer Survivors Best Practice, Patient Navigation, Referral - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 330 | 2026-12-09 | 2026-10-23 |
| Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer Patients Electronic Health Record Review, Minoxidil, Revian RED LED-light cap - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 50 | 2026-11-15 | 2026-09-02 |
| A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine, Recombinant Granulocyte-Macrophage Colony-Stimulating Factor, Biospecimen Collection - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Not yet recruiting | University of Washington | 60 | 2026-11-01 | 2026-10-16 |
| Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial Aerobic Exercise, Biospecimen Collection, Dietary Intervention - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Not yet recruiting | Ohio State University Comprehensive Cancer Center | 90 | 2026-10-10 | 2026-07-23 |
| Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial Exercise Intervention, Educational Intervention, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Recruiting | Wake Forest University Health Sciences | 120 | 2026-10-02 | 2026-10-06 |
| A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial Accelerometry, Aerobic Exercise, Electronic Health Record Review - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Not yet recruiting | Mayo Clinic | 10 | 2026-10-01 | 2026-06-16 |
| A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer Best Practice, Interview, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Recruiting | City of Hope Medical Center | 126 | 2026-09-09 | 2026-10-16 |
| Transcranial Direct Current Stimulation to Improve Gait for Breast Cancer Survivor's Who Received Taxene and/or Platinum Chemotherapy Sham Intervention, Survey Administration, Transcranial Direct Current Stimulation - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Not yet recruiting | University of Michigan Rogel Cancer Center | 60 | 2026-09-01 | 2026-10-08 |
| Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase Inhibitors Biospecimen Collection, Dual X-ray Absorptiometry, Functional Assessment - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 4 | Not yet recruiting | Mayo Clinic | 50 | 2026-09-01 | 2026-08-17 |
| Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer Best Practice, Internet-Based Intervention, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 50 | 2026-07-15 | 2026-08-06 |
| Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients Biospecimen Collection, Goserelin Acetate, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | Mayo Clinic | 98 | 2026-05-22 | 2026-10-01 |
| Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial Abemaciclib, Biospecimen Collection, Imlunestrant - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 42 | 2026-05-18 | 2026-08-20 |
| Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer Biospecimen Collection, Electronic Health Record Review, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Withdrawn | City of Hope Medical Center | 2026-05-12 | 2026-06-25 | |
| A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial Starch, Potato - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Recruiting | University of Michigan Rogel Cancer Center | 20 | 2026-04-22 | 2026-04-24 |
| Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial Biospecimen Collection, Electronic Health Record Review, Goserelin - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | University of Michigan Rogel Cancer Center | 75 | 2026-01-22 | 2026-06-23 |
| Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer Ipilimumab, Pembrolizumab, Vaccine Therapy - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Recruiting | Emory University | 18 | 2025-12-02 | 2026-01-26 |
| Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial Biospecimen Collection, Hormone Therapy, Pembrolizumab - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 120 | 2025-10-09 | 2026-09-24 |
| ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab Trastuzumab (Herceptin), Pertuzumab, Echocardiography - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 3 | Recruiting | Alliance for Clinical Trials in Oncology | 1524 | 2025-09-17 | 2026-10-02 |
| Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer Cone-Beam Computed Tomography, Hypofractionated External Beam Radiation Therapy, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Phase 2 | Recruiting | City of Hope Medical Center | 82 | 2025-08-28 | 2025-10-29 |
| The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients Non-Interventional Study - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Recruiting | Ohio State University Comprehensive Cancer Center | 100 | 2025-08-18 | 2026-01-14 |
Showing 20 of 119. Sign in to see all of them.
Breast Carcinoma In Situ (24) · Breast Neoplasms (19) · Triple Negative Breast Neoplasms (14) · Carcinoma, Intraductal, Noninfiltrating (9) · Colorectal Neoplasms (4) · Lung Neoplasms (4) · Ovarian Neoplasms (4) · Endometrial Neoplasms (3) · Overweight (3) · Prostatic Neoplasms (3) · Uterine Cervical Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Motor Activity (2) · Obesity (2) · Anxiety Disorders (1)
Neoplasms (63) · Neoplasms by Site (56) · Breast Diseases (46) · Skin Diseases (46) · Skin and Connective Tissue Diseases (46) · Neoplasms by Histologic Type (34) · Carcinoma (32) · Neoplasms, Glandular and Epithelial (32) · Carcinoma in Situ (30) · Breast Neoplasms (27) · Adenocarcinoma (11) · Neoplasms, Ductal, Lobular, and Medullary (11) · Genital Diseases (9) · Urogenital Diseases (9) · Urogenital Neoplasms (8)
Specimen Handling (26) · Practice Guidelines as Topic (16) · Standard of Care (14) · Early Intervention, Educational (9) · Educational Status (7) · Interviews as Topic (7) · Methods (7) · Taxes (7) · Paclitaxel (6) · Palliative Care (6) · Magnetic Resonance Spectroscopy (5) · Docetaxel (4) · Letrozole (4) · Nutrition Assessment (4) · Behavior Therapy (3)
Mayo Clinic (25) · M.D. Anderson Cancer Center (15) · Ohio State University Comprehensive Cancer Center (15) · City of Hope Medical Center (7) · Emory University (6) · Fred Hutchinson Cancer Center (6) · Jonsson Comprehensive Cancer Center (6) · Alliance for Clinical Trials in Oncology (4) · University of Michigan Rogel Cancer Center (4) · University of Washington (4) · OHSU Knight Cancer Institute (3) · SWOG Cancer Research Network (3) · Thomas Jefferson University (3) · University of Southern California (3) · Wake Forest University Health Sciences (3)
United States (116) · Puerto Rico (3) · Mexico (2) · Canada (1) · Chile (1) · Colombia (1) · Italy (1) · Peru (1)
Heather Greenlee (4) · Norah L Henry (3) · Brittany L Dulmage, MD (2) · Carlos E. Vargas, M.D. (2) · Lorenzo Cohen (2) · Meghan Karuturi (2) · Meghan Karuturi, MD (2) · Patricia A Ganz (2) · Saranya Chumsri (2) · Saranya Chumsri, MD (2) · Senthilkumar Damodaran (2) · Timiya Nolan, PhD (2) · Abenaa M Brewster (1) · Adrienne Waks, MD (1) · Alexandra Zimmer, M.D. (1)
PMID 33142018, PMID 34461975, PMID 34636255, PMID 34741653, PMID 34782341, PMID 35727609, PMID 35788100, PMID 36228112, PMID 36336249, PMID 36435952, PMID 36609349, PMID 37621406, PMID 37828596, PMID 38828938, PMID 39325778, PMID 39395534, PMID 39865083, PMID 40073831, PMID 40658949, PMID 40966714, PMID 41165048, PMID 41213254, PMID 41835341, PMID 42077327, PMID 42804742
P30CA033572 (7), P30CA138292 (6), P30CA014089 (3), P30CA012197 (2), P30CA015083 (2), P30CA015704 (2), P30CA016672 (2), UG1CA189823 (2), UG1CA189974 (2), K08CA245208 (1), K23AG090624 (1), K23HL183845 (1), K76AG074918 (1), N01CN00033 (1), P30CA014520 (1)